Purpose: The present study was designed to clarify the direct effects of the volatile anesthetics halothane, isoflurane and sevoflurane on oxytocin-induced uterine smooth muscle contraction from pregnant rats.
relaxation are not fully known. 5, 6 As in other smooth muscles, intracellular free Ca + + is a primary regulator of uterine smooth muscle contraction, 7 and Ca + + influx through membrane-associated voltage-dependent Ca ++ channels (VDCCs) is important for the regulation of the concentration ([Ca + + ] i ). 8 The present study was, therefore, designed to clarify the direct effects of the volatile anesthetics halothane, isoflurane and sevoflurane on oxytocin-induced uterine smooth muscle contraction in the pregnant rat by simultaneously measuring the muscle tension and [Ca + + ] i using a fluorescence technique 9 , 1 0 and by measuring VDCC activity using a patch clamp technique. 11, 12 Methods The experimental protocol was approved by the Sapporo Medical University Animal Care and Use Committee. Twenty-four rats (Sprague-Dawley, weighing 200-250 g) in the late stage of gestation (19-21 days) were anesthetized, the uteri were excised quickly, and the longitudinal muscle layer of each uterus was isolated.
The muscle tissue was cut into small strips (2-mm wide and 15-mm long), and the strips were loaded with 5 µM acetoxymethyl ester of fura-2, an indicator of Ca + + . Each fura-2-loaded muscle strip was held in an organ bath (37°C), and one end of the muscle strip was connected to a strain gauge transducer. Experiments were performed using a fluorescence spectrometer (CAF-100; Japan Spectroscopic, Tokyo, Japan). Excitation light was passed through 340-and 380-nm rotating filters. The light emitted from the muscle strip at 500 nm was measured, and the ratio of the fluorescence (R 340/380 ) was used as an indicator of [Ca + + ] i . 9, 10 The tissue was contracted with 20 nM oxytocin, a potent contractile agonist. Halothane, isoflurane, or sevoflurane (1, 2, and 3%, respectively) were randomly introduced into the tissue bath through bubbling in the presence of oxytocin. Volatile anesthetic concentrations in the gas phase during the bubbling were continuously monitored with a calibrated mass spectrometer (ATOM 303; ATOM, Tokyo, Japan). In order to express the quantitative changes in muscle contractility and in [Ca + + ] i , the areas under the contraction and [Ca + + ] i curves were measured for five minutes using Sigma Plot (Jandel Scientific, Corte Madera, CA, USA). 1 3 Conventional whole cell patch clamp techniques 11, 12 were used to observe the inward current through VDCCs. Uterine smooth muscle tissues were minced and digested in Ca + + -free modified Tyrode's solution to which 0.05% (w/v) collagenase (Lot#: 034-10533) had been added. Cells were then dispersed by trituration, filtered by nylon mesh, and centrifuged. The pellet was resuspended in a modified Kraftbrühe solution 1 4 and stored at 4°C for up to five hours before use. Micropipettes had resistances of 3-5 MS, and the pipette solution contained (in mM) CsCl 20, CsOH 110, MgCl 2 5.2, L-glutamate 112, EGTA 10, Na 2 ATP 5.0, and HEPES 10, with the pH adjusted to 7.2 with Tris. The bath solution contained (in mM) tetraethylammonium chloride 130, MgCl 2 1.0, BaCl 2 5.0, glucose 10, and HEPES 10, with the pH adjusted to 7.35 with Tris. Ba + + was used, instead of Ca + + , in order to prevent an indirect inhibitory effect of oxytocin on VDCC activity. An aliquot of the cell suspension was placed in a temperature-controlled chamber (37°C), and the patch membrane was disrupted by strong negative pressure. Membrane currents were monitored using a patch clamp amplifier (CEZ-2400; Nihon Kohden, Tokyo, Japan), and the amplifier output was low-pass-filtered at 2,000 Hz. Inward Ba + + currents through VDCCs (I Ba s) were elicited by 100-msec depolarizing pulses from a holding potential of -60 mV. Leak currents were subtracted, and membrane capacitance and series resistance were compensated. After obtaining a stable baseline of peak I Ba with 20 nM oxytocin, cells were then exposed to bath solution equilibrated with one of three volatile anesthetics: halothane, isoflurane or sevoflurane (1, 2, or 3%, respectively).
The following drugs and chemicals were used: acetoxymethyl ester of fura-2 (Dojindo, Kumamoto, Japan), oxytocin (Sigma Chemical, St. Louis, MO, USA), collagenase (Wako Pure Chemical, Osaka, Japan), halothane (ICI, Dighton, MA, USA), isoflurane (Ohio Medical Products, Madison, WI, USA), and sevoflurane (Maruishi Pharmaceutical, Osaka, Japan).
Data are expressed as means ± SD. For the measurement of [Ca + + ] i and muscle tension, oxytocininduced changes in [Ca + + ] i ( R 340/380 ) and muscle tension were used as references. 9, 10 Changes in peak I Ba with exposure to anesthetics were compared at each applied potential by the paired, two-tailed t test. Other data were analyzed using one-way ANOVA for repeated measurements with Fisher's test. In all comparisons, P <0.05 was considered significant.
Results
In resting conditions, oscillatory phasic contractions of the uterine smooth muscle strips with a concomitant oscillatory increase in [Ca ++ ] i were observed ( Figure 1A ). Treatment with 20 nM oxytocin significantly increased oscillatory rates (3. Relationships between peak I B a at +10 mV, expressed as percentage of control, and the concentrations of volatile anesthetics in the gas phase. Symbols represent means ± SD (n=6 at each point). *P <0.05, **P <0.01 vs control without the anesthetic. potencies for both the muscle tension and [Ca + + ] i was halothane > isoflurane > sevoflurane.
The I Ba seen in dispersed rat uterine smooth muscle cells peaked at approximately 10-15 msec and was inactivated slowly with a time constant of approximately 300-500 msec (Figure 2A: control) . In baseline conditions, threshold activation of I Ba occurred at approximately -40 mV, and maximum peak current amplitude was obtained at approximately +10 mV ( Figure 2B) . In 12 cells, the maximum peak I Ba was -389 ± 89 pA. Nifedipine (1 µM) completely inhibited the currents (data not shown, n=3). As shown in a representative trace for depolarization from -60 to +10 mV ( Figure  2A : sevoflurane), 3% sevoflurane inhibited the magnitude of I Ba but did not obviously alter the time course of the current. Sevoflurane significantly inhibited I Ba at step potentials ranging from -20 mV to +40 mV and decreased peak I Ba by approximately 33% ( Figure 2B ). There was no apparent shift in the voltage dependence of I Ba with sevoflurane. The other two volatile anesthetics showed similar inhibitory effects on I Ba (data not shown). Figure 2C shows the relationships between the percentage of control peak I Ba at +10 mV and the % anesthetic concentrations of volatile anesthetics in the gas phase. All three volatile anesthetics significantly inhibited the peak I Ba in a dose-dependent manner, and the order of inhibitory potencies for I Ba was halothane >isoflurane >sevoflurane.
Discussion
The present study showed that the volatile anesthetics tested significantly inhibited agonist-induced pregnant uterine smooth muscle contraction, at least in part, by decreasing [Ca ++ ] i . This result for muscle tension is consistent with those obtained by Naftalin et al. 1 5 and by Munson et al. 1 6 using rat and human uterine smooth muscles, respectively. This result is also in agreement with the general observations in airway 10, 17 and in vascular 1 8 smooth muscles. Inositol 1,4,5-triphosphate (IP 3 )-induced Ca + + release from intracellular Ca + + stores, especially the sarcoplasmic reticulum, and Ca + + influx through VDCCs are both important for the oxytocin-induced uterine smooth muscle contraction during delivery. 8 , 1 3 Phillippe et al. 8, 13, 19 demonstrated that activation of the IP 3 -signaling pathway results in the development of intracellular Ca ++ oscillation phenomena. Ca + + influx through VDCCs is also essential for the maintenance of repetitive contractions, 7, 13 because the blockade of Ca + + influx through VDCCs by nifedipine completely blocked the oscillatory contractions in this study. Therefore, the mechanisms by which volatile anesthetics decreased [Ca + + ] i are thought to be, at least in part, due to an inhibition of VDCC activity.
Using a whole-cell patch clamp technique, we measured depolarization-induced I Ba in rat uterine smooth muscle cells. Based on their time and voltage dependencies and their sensitivity to blockade by nifedipine, these currents are presumed to reflect the activity of Ltype VDCCs. 20, 21 Volatile anesthetics significantly inhibited I Ba through L-type VDCCs of the uterine smooth muscle cells without an apparent change in the kinetics of activation and inactivation (Figure 2 ). Volatile anesthetics did not alter the voltage dependence of I Ba , suggesting that these anesthetics have no effect on membrane surface charge or on the voltage sensor of the channel. These data indicate one of the cellular effects of volatile anesthetics that can account for the uterine smooth muscle relaxant effects of the anesthetics. 15, 16 We did not investigate other second messengers such as IP 3 and cyclic AMP. IP 3 can release Ca + + from the sarcoplasmic reticulum and also activates VDCCs directly. 1 3 Since it was reported that halothane inhibits the agonist-induced increase in IP 3 concentration in canine tracheal smooth muscle, 2 2 it is possible that the anesthetic also decreases IP 3 concentration in uterine smooth muscle. Furthermore, Yang et al. 6 reported that halothane increases intracellular concentration of cyclic AMP in rat uterine smooth muscle. An increase in cyclic AMP concentration can decrease [Ca ++ ] i , leading to uterine smooth muscle relaxation. Further studies are, therefore, needed to clarify the relative importance of the inhibitory effect of the volatile anesthetics on VDCC activity.
We did not measure the exact concentrations of the volatile anesthetics in the bathing chamber and showed our data using percent anesthetic concentrations in the gas phase, because the systems (both fluorescence and patch-clamp techniques) used in this study were the same as those we had used in our previous studies. 10, 17, 23 Minimum alveolar concentrations (MACs) of the volatile anesthetics halothane, isoflurane and sevoflurane in adult rats are 1.03%, 24 1.46% 2 4 and 2.68%, 2 5 respectively. Although the effect of pregnancy on the MAC of sevoflurane has not been reported in rats, it has been shown that the MACs of halothane and isoflurane are not affected by either sex or pregnancy. 2 4 When the anesthetic concentrations were expressed as MACs, differences in inhibitory potencies of the volatile anesthetics tested for muscle tension, [Ca ++ ] i or VDCC activity became indistinguishable. Therefore, the three volatile anesthetics tested in this in vitro study appear to be equivalent for general anesthesia in obstetric surgery, as far as uterine contraction is concerned and in as much as our in vitro results apply to the clinical situation.
In conclusion, the volatile anesthetics halothane, isoflurane and sevoflurane at clinically relevant concentrations (1-3%) significantly reduce the oxytocin-induced contraction of isolated preparations of uterine smooth muscle obtained from pregnant rats. Inhibition of the contraction by the volatile anesthetics is due, at least in part, to the decrease in [Ca + + ] i , and the decrease in [Ca + + ] i may be mediated by inhibition of VDCC activity.
